Bill Snyder Archive — Page 33 of 118
-
April 20, 2022
Lehmann named to receive Vanderbilt Prize in Biomedical Science
Renowned developmental geneticist Ruth Lehmann, PhD, is the recipient of the 2022 Vanderbilt Prize in Biomedical Science. -
April 14, 2022
VUMC research team receives $1 million grant from AHA to study impact of long-COVID on heart
A research team led by Cyndya Shibao, MD, MSCI, associate professor of Medicine at Vanderbilt University Medical Center (VUMC), has received a three-year, $1-million grant from the American Heart Association to study long-term effects of COVID-19 on the heart and cardiovascular system. -
April 13, 2022
40th annual Research Forum hosted by GME office
Matthew Clark, MD, clinical fellow in Pediatric Rheumatology at Vanderbilt University Medical Center, won the Elliott V. Newman Prize for best abstract during the 40th annual Research Forum hosted April 5 by the VUMC Office of Graduate Medical Education and House Staff Advisory Council. VUMC House Staff presented Dario Englot, MD, PhD, assistant professor of Neurological Surgery and Surgical Director of Epilepsy, with the Grant W. Liddle Award for his “commitment and leadership in promoting an interest in research among young physicians.” -
April 7, 2022
Vanderbilt Prize winner Regev to deliver April 14 Discovery Lecture
Aviv Regev, PhD, recipient of the 2021 Vanderbilt Prize in Biomedical Science, will deliver her Vanderbilt Prize Discovery Lecture at 4 p.m. next Thursday, April 14, in 208 Light Hall. -
April 6, 2022
Major grant renewal to provide five more years of support for VICTR
Vanderbilt University Medical Center has competed successfully for a third renewal of its Clinical and Translational Science Award by the National Institutes of Health. -
March 31, 2022
Crowe receives national award for COVID antibody research
Vanderbilt's James Crowe Jr., MD, and Michel Nussenzweig, MD, PhD, of The Rockefeller University, have been jointly awarded the 2022 Harrington Prize for Innovation in Medicine for “groundbreaking work” that enabled the use of human antibodies to treat COVID-19.